Geno Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Goa, Goa, India, established in 1975.
1975 Goa, Goa, India Active
Last Updated:
Access Report
About Geno Pharmaceuticals Private Limited

Geno Pharmaceuticals Private Limited, a active private limited company, was established on 04 December 1975 in Goa, Goa, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239GA1975PTC000250. Registered under ROC Roc Goa. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹3.00 Cr.

Formerly known as Geno Pharmaceuticals Limited. It upholds a compliant status. Employing 1,042 professional, Its leadership includes Dilip Salgaocar Ramacrisna (Director), Sagar Dilip Salgaocar (Managing Director), Pramod Dilip Salgaocar (Whole-Time Director). Past directors included Dilip Salgaocar Ramacrisna, Sagar Dilip Salgaocar, Pramod Dilip Salgaocar. It holds ₹136.64 Cr open charges and ₹96.95 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Tivim Industrial Estatekasarwada Mapusa, Goa, Goa.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239GA1975PTC000250

  • Registration Number

    000250

  • Incorporation Date

    04 December 1975

  • Authorized Capital

    ₹6.50 Cr

  • Paid-Up Capital

    ₹3.00 Cr

  • ROC Code

    Roc Goa

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.50 Cr
  • Paid Up Capital ₹ 3.00 Cr
  • Company Age 50 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 136.64 Cr
  • Satisfied Charges ₹ 96.95 Cr
  • Revenue Growth **** 7.50%
  • Profit Growth **** -9.25%
  • Ebitda **** -2.84%
  • Net Worth 7.76%
  • Total Assets **** 7.39%
Company report

Geno Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Geno Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Geno Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dilip Salgaocar Ramacrisna Director 01 Jan 1980 Current
Sagar Dilip Salgaocar Managing Director 01 Oct 2010 Current
Pramod Dilip Salgaocar Whole-Time Director 30 Sep 2006 Current
Shivam Sagar Salgaocar Director 23 Oct 2023 Current
Pallavi Sagar Salgaocar Whole-Time Director 30 Sep 2004 Current
Suriakiran Umacanta Sinaikunde Director 25 Oct 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 14 Nov 2021 Past
Pramod Abcsdd Director 01 Oct 2016 Past
Pramod Abcsdd Director 01 Oct 2006 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 25 Oct 2014 Past
Pramod Abcsdd Additional Director 29 Nov 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Geno Pharmaceuticals.

Geno Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.5% increase. The company also saw a slight decrease in profitability, with a 9.25% decrease in profit. The company's net worth moved up by a moderate rise of 7.76%.

Geno Pharmaceuticals revenue growth over time
Geno Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 7.50%
*******
*******
*******
*******
Revenue from Operations
*******
 8.75%
*******
*******
*******
*******
Total Assets
*******
 7.39%
*******
*******
*******
*******
Profit or Loss
*******
 -9.25%
*******
*******
*******
*******
Net Worth
*******
 7.76%
*******
*******
*******
*******
EBITDA
*******
 -2.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Geno Pharmaceuticals?

In 2024, Geno Pharmaceuticals had a promoter holding of 90.10% and a public holding of 9.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,366,373,870.00

Satisfied Charges

₹969,534,353.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 89.39 Cr
  • Canara Bank : 43.00 Cr
  • State Bank Of India : 4.23 Cr
  • Mapusa Urban Co-Operation Ltd. : 0.02 Cr
Latest Charge Details
Date Lender Amount Status
25 Sep 2025 Hdfc Bank Limited ₹4.39 Cr Open
01 Sep 2025 Hdfc Bank Limited ₹85.00 Cr Open
11 Mar 2022 State Bank Of India ₹4.23 Cr Open
26 Dec 2013 Canara Bank ₹43.00 Cr Open
18 Nov 1983 Mapusa Urban Co-Operation Ltd. ₹0.20 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Geno Pharmaceuticals?

Geno Pharmaceuticals has a workforce of 1042 employees as of Jan 30, 2026. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Geno Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Geno Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Geno Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Geno Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 4.39 Cr with Charge ID 101165122 was registered on 25 Sep 2025. was documented.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 85.00 Cr registered on 01 Sep 2025 with Charge ID 101147312 was modified on 08 Sep 2025. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 85.00 Cr with Charge ID 101147312 was registered on 01 Sep 2025. was recorded as a recent event.

  • Charges

    A charge with Canara Bank of Rs. 43.00 Cr registered on 26 Dec 2013 with Charge ID 10470582 was modified on 29 May 2025. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 09 Mar 2022 via Charge ID 100554721 with Others was fully satisfied on 16 Apr 2025. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Geno Pharmaceuticals Private Limited?

The CIN of Geno Pharmaceuticals Private Limited is U24239GA1975PTC000250.

Where is Geno Pharmaceuticals Private Limited headquartered?

Geno Pharmaceuticals Private Limited is headquartered at Tivim Industrial Estatekasarwada Mapusa, Goa, Goa.

When was Geno Pharmaceuticals Private Limited incorporated?

Geno Pharmaceuticals Private Limited was incorporated on 04 December 1975.

Who are the current directors of Geno Pharmaceuticals Private Limited?

The current directors of Geno Pharmaceuticals Private Limited are

What is the primary industry of Geno Pharmaceuticals Private Limited?

The primary industry of Geno Pharmaceuticals Private Limited is Manufacturing.

Is Geno Pharmaceuticals Private Limited a listed company?

Geno Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Geno Pharmaceuticals Private Limited?

The authorized capital of Geno Pharmaceuticals Private Limited is ₹6.50 Cr, and the paid-up capital is ₹3.00 Cr.

What is the compliance status of Geno Pharmaceuticals Private Limited?

The compliance status of Geno Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available